“inflammatory-diseases” Archives

Entry Author Date Location
Seattle’s Adaptive Bio to Base New Drug-Hunting Team in San Diego 03/17/16 San Diego
With Eye Drug Data, Aldeyra Takes a Small Step Forward in Inflammation 02/29/16 Boston
San Diego Life Sciences Roundup: Sophiris, Isis, Qualcomm, & More 08/08/13 San Diego
Ensemble Reels in Novartis to Develop Oral, Mid-Sized Inflammation Drugs 08/06/13 Boston
Isis Ends Program, Still Has Options For Rheumatoid Arthritis Drug 08/05/13 San Diego
San Diego Life Sciences Roundup: IPOs, ResMed, Ventrix, CovX, & More 02/21/13 San Diego
U-M’s New Drug Discovery Center to Commercialize Research 09/05/12 Detroit Ann Arbor
Innovimmune Pursues Pharma Partners, Shuns VCs 08/07/12 New York
Xconomist of the Week: John Reed on Sanford-Burnham’s Drug Pipeline 08/03/12 San Diego
SD Life Sciences Roundup: Arena, PatientSafe, MEI Pharma, & More 06/28/12 San Diego
Aileron CEO Hails Expanded Roche Deal as a Validation of Stapled-Peptide Drug Technology 11/17/11 Boston
Xoma CEO Resigns After Four-Year Push To Go Commercial 08/31/11 San Francisco
Dicerna Expands Kyowa Hakko Pact 12/07/10 Boston
Logical Therapeutics Closes $16.9M C Round 05/27/10 Boston
Another $8M for Dyax in Stock Deal 04/05/10 Boston
Epizyme Snags $32M Round to Make Drugs Against Cancer and More 10/07/09 Boston
Axikin Raises $3M After Spinning Out From Actimis 01/22/09 San Diego
CalciMedica Finds a New Pathway to Fight Autoimmune Disorders 01/09/09 San Diego
Ardea Raises $30.6M in Stock Sale 12/19/08 San Diego
Clinical Data Acquires Adenosine To Expand Drug Pipeline 08/05/08 Boston
Page 1 of 1